65.65
                                            Schlusskurs vom Vortag:
              $67.16
            Offen:
              $68
            24-Stunden-Volumen:
                2.33M
            Relative Volume:
              1.30
            Marktkapitalisierung:
                $3.49B
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-38.99M
            KGV:
              -21.91
            EPS:
                -2.9966
            Netto-Cashflow:
                $-24.94M
            1W Leistung:
              -2.76%
            1M Leistung:
              +10.88%
            6M Leistung:
                -12.73%
            1J Leistung:
              +17.53%
            Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
                  
                      Soleno Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      650-213-8444
                    
                Adresse
                  
                      100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
                    
                Vergleichen Sie SLNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                SLNO
                            
                             
                        Soleno Therapeutics Inc 
                           | 
                    65.65 | 3.57B | 0 | -38.99M | -24.94M | -2.9966 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-07 | Eingeleitet | Goldman | Buy | 
| 2025-08-20 | Eingeleitet | Wells Fargo | Overweight | 
| 2025-06-23 | Eingeleitet | TD Cowen | Buy | 
| 2025-03-05 | Fortgesetzt | Stifel | Buy | 
| 2024-12-02 | Bestätigt | Robert W. Baird | Outperform | 
| 2024-12-02 | Bestätigt | Stifel | Buy | 
| 2024-09-03 | Eingeleitet | H.C. Wainwright | Buy | 
| 2024-05-10 | Eingeleitet | Robert W. Baird | Outperform | 
| 2024-02-05 | Eingeleitet | Piper Sandler | Overweight | 
| 2024-01-23 | Eingeleitet | Stifel | Buy | 
| 2023-11-21 | Fortgesetzt | Guggenheim | Buy | 
| 2020-09-29 | Eingeleitet | Guggenheim | Buy | 
| 2020-01-10 | Eingeleitet | Craig Hallum | Buy | 
| 2019-12-23 | Eingeleitet | Oppenheimer | Outperform | 
| 2018-02-13 | Bestätigt | Maxim Group | Buy | 
                    Alle ansehen
                    
                  
                Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
Is Soleno Therapeutics Inc. (6XC) stock good for long term investingAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Real time social sentiment graph for Soleno Therapeutics Inc.Analyst Downgrade & Risk Controlled Daily Plans - newser.com
How Soleno Therapeutics Inc. (6XC) stock moves on employment dataTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull marketTrend Reversal & Accurate Entry/Exit Alerts - newser.com
Soleno Therapeutics Q3 Earnings Preview - MSN
Hot Picks: Investor highlights small-cap opportunities in energy, industrial tech and biotech - BNN Bloomberg
Has Soleno Therapeutics Inc. formed a bullish divergence2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Published on: 2025-11-03 08:08:49 - newser.com
Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
Will Soleno Therapeutics Inc. stock reach Wall Street targetsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com
Full technical analysis of Soleno Therapeutics Inc. stockWeekly Trade Summary & AI Optimized Trading Strategy Guides - newser.com
What data driven models say about Soleno Therapeutics Inc.’s future2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Will Soleno Therapeutics Inc. outperform the marketJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
How moving averages guide Soleno Therapeutics Inc. tradingAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock outperform small cap peersPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Order flow analysis tools used on Soleno Therapeutics Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
What hedge fund activity signals for Soleno Therapeutics Inc. stock2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Moody Aldrich Partners LLC Has $3.48 Million Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
How Soleno Therapeutics Inc. stock benefits from strong dollarJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Soleno Therapeutics, Inc. $SLNO Shares Acquired by Emerald Mutual Fund Advisers Trust - MarketBeat
Is Soleno Therapeutics Inc. a candidate for recovery play2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levelsEarnings Overview Summary & Real-Time Chart Pattern Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Risk Summary & Daily Market Momentum Tracking - newser.com
Soleno Therapeutics (SLNO): Assessing Valuation Following Securities Probe and Short-Seller Safety Allegations - Sahm
Strategies to average down on Soleno Therapeutics Inc.July 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Will Soleno Therapeutics Inc. stock outperform tech sector in 2025Portfolio Return Report & Safe Entry Zone Identification - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Bluefield Daily Telegraph
Soleno Therapeutics (SLNO) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Soleno Therapeutics, Inc. $SLNO is Emerald Advisers LLC's 6th Largest Position - MarketBeat
Soleno Therapeutics Stock Jumped 5.2% in a Day, What Now? - Trefis
What analysts say about Soleno Therapeutics Inc stockGap Up/Gap Down Analysis & Never Miss the Next Wealth Opportunity - earlytimes.in
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):